Alzheimer’s disease affects more than 30m people worldwide, mostly the elderly. After the age of 65, the chance of developing ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

The findings suggest that mild or moderate Covid-19 may accelerate biological processes that contribute to the buildup of disease-promoting amyloid in the brain.

A new study showed that people who took longer to enter this dream phase of sleep had higher levels of amyloid beta and tau, ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.